Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

Share

Karo Pharma AS

Closing information (x1000 EUR)

Closing information 2024/12 2023/12 2022/12
Turnover 60,294 More Arrow 61,566 Less Arrow 60,868
Financial expenses 382 More Arrow 1,441 Less Arrow 879
Earnings before taxes 15,829 Less Arrow 14,361 Less Arrow 11,989
Total assets 42,397 Less Arrow 39,995 Less Arrow 36,201
Current assets 39,305 Less Arrow 36,552 Less Arrow 32,143
Current liabilities 25,278 More Arrow 26,558 Less Arrow 22,113
Equity capital 17,118 Less Arrow 13,437 More Arrow 14,087
- share capital 574 More Arrow 605 More Arrow 646

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 40.4% Less Arrow 33.6% More Arrow 38.9%
Turnover per employee
Profit as a percentage of turnover 26.3% Less Arrow 23.3% Less Arrow 19.7%
Return on assets (ROA) 38.2% More Arrow 39.5% Less Arrow 35.5%
Current ratio 155.5% Less Arrow 137.6% More Arrow 145.4%
Return on equity (ROE) 92.5% More Arrow 106.9% Less Arrow 85.1%
Change turnover 1,874 More Arrow 4,566 More Arrow 12,964
Change turnover % 3% More Arrow 8% More Arrow 27%
Chg. No. of employees
Chg. No. of employees %

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.